Stockscreener 앱 받기
26.00
0.19%
-0.05
시장 영업 전:
26.44
0.44
+1.69%
전일 마감가:
$26.05
열려 있는:
$26.99
하루 거래량:
623.42K
Relative Volume:
0.71
시가총액:
$2.83B
수익:
$322.71M
순이익/손실:
$-298.33M
주가수익비율:
-8.6667
EPS:
-3
순현금흐름:
$-218.98M
1주 성능:
+7.04%
1개월 성능:
-2.69%
6개월 성능:
+39.34%
1년 성능:
+10.92%
1일 변동 폭
$25.71
$27.24
1주일 범위
$23.82
$27.24
52주 변동 폭
$13.48
$36.60
Zai Lab Limited Adr Stock (ZLAB) Company Profile
명칭
Zai Lab Limited Adr
전화
862161632588
주소
4560 JINKE ROAD, SHANGHAI
ZLAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
26.00 | 2.83B | 322.71M | -298.33M | -218.98M | -3.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-14 | 개시 | Morgan Stanley | Overweight |
| 2023-08-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-21 | 개시 | Macquarie | Outperform |
| 2021-10-12 | 개시 | Bernstein | Mkt Perform |
| 2020-04-28 | 개시 | Goldman | Buy |
| 2020-04-15 | 개시 | Guggenheim | Buy |
| 2019-07-12 | 개시 | BofA/Merrill | Buy |
| 2019-07-05 | 개시 | Macquarie | Outperform |
| 2019-01-29 | 개시 | Credit Suisse | Outperform |
| 2018-11-21 | 개시 | Jefferies | Buy |
| 2018-06-21 | 재개 | Leerink Partners | Outperform |
| 2018-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 개시 | JP Morgan | Neutral |
| 2017-10-16 | 개시 | Leerink Partners | Outperform |
모두보기
Zai Lab Limited Adr 주식(ZLAB)의 최신 뉴스
Here’s Why Analysts Are Bullish on Zai Lab Limited (ZLAB) - Insider Monkey
Zai Lab Limited (NASDAQ:ZLAB) Position Decreased by JPMorgan Chase & Co. - Defense World
Schrodinger Inc (NASDAQ: SDGR) Up 1.66%: This Is What Analysts Are Now Forecasting - Stocks Register
Sage Therapeutics (SAGE) Moves 35.1% Higher: Will This Strength Last? - Yahoo Finance
Vertex Pharmaceuticals Incorporated and Zai Lab Limited Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore - Marketscreener.com
Geode Capital Management LLC Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate - Business Wire
Zai Lab Secures Debt Facility to Bolster Financial Standing - TipRanks
Rafael Amado Sells 7,583 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock - MarketBeat
Zai Lab Limited (NASDAQ:ZLAB) Shares Sold by State Street Corp - Defense World
Zai Lab (NASDAQ:ZLAB) Shares Gap Down – What’s Next? - Defense World
Zai Lab Limited (ZLAB) Upgraded to Buy: What Does It Mean for the Stock? - MSN
BNP Paribas Financial Markets Has $31,000 Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Announces Participation in Investor Conference in January 2025 - Business Wire
Janus Henderson Group PLC Increases Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Zai Lab Limited ADR (NASDAQ: ZLAB) Could Pass $101 In One Year Stock Forecast - Stocks Register
Bamco Inc. NY Increases Stake in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Stocks to Watch Monday: Stellantis, Tesla, Intel, Super Micro - The Wall Street Journal
Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer - Business Wire
Daiwa Securities Group Inc. Purchases 9,364 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Algert Global LLC Makes New Investment in Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
(repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List - Business Wire
The week in pharma: action, reaction and insight – week to November 22 - The Pharma Letter
Is Enviri Corp (NYSE: NVRI) A Good Pick For New Investors Now? - Stocks Register
Can Controladora Vuela Cia De Aviacion ADR (NYSE: VLRS) Be A Safe Investment Now? - Stocks Register
Zai Lab Grants Share Units to Employees - Marketscreener.com
Connor Clark & Lunn Investment Management Ltd. Acquires 125,532 Shares of Zai Lab Limited (NASDAQ:ZLAB) - MarketBeat
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO - Business Wire
Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics - MSN
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares - BioSpace
ZLABZai Lab Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan
FY2024 EPS Estimates for Zai Lab Increased by Analyst - Defense World
Zai Lab (NASDAQ:ZLAB) Sees Strong Trading Volume – Here’s What Happened - Defense World
Digital Brands Group Inc (DBGI): Is It Worth A Small Bite At $0.10? - Stocks Register
Thermo Fisher Scientific Inc’s (TMO) Stock Is Harder To Predict Than You Think - Stocks Register
Selling Your MicroAlgo Inc (NASDAQ: MLGO) Stock? Here’s What You Need To Know - Stocks Register
Danaher Corp (DHR): An Important Analyst Insights - Stocks Register
Centerpoint Energy Inc (NYSE: CNP): Blank Check On Growth? - Stocks Register
Do Unitedhealth Group Inc (NYSE: UNH) Provide Stability And Growth? - Stocks Register
Major Improvements In VF Corp (VFC) Stock Need To Be Considered - Stocks Register
A Stock Analysis Of Fortive Corp’s (FTV) - Stocks Register
Dollar Tree Inc’s (DLTR) Stock Is Harder To Predict Than You Think - Stocks Register
BioNTech SE ADR (BNTX): An Important Analyst Insights - Stocks Register
Leerink Partnrs Increases Earnings Estimates for Zai Lab - Defense World
Zai Lab Announces $200M Public Offering at $25.50 per ADS | ZLAB Stock News - StockTitan
Zai Lab Announces Pricing of Public Offering of American Depositary Shares - Business Wire
Janus Henderson Group's Strategic Acquisition of Zai Lab Shares - GuruFocus.com
Zai Lab Announces Proposed Public Offering of American Depositary Shares - Business Wire
Zai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to Profitability - Yahoo Finance
Zai Lab Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Zai Lab Ltd (ZLAB) Reports Q3 2024 Earnings: EPS Loss of $0.04, Revenue at $101.8 Million, Slightly Misses Estimates - GuruFocus.com
Zai Lab Limited Adr (ZLAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):